Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
University of Pittsburgh
Royal Marsden NHS Foundation Trust
Alliance for Clinical Trials in Oncology
University of Chicago
University of Cincinnati
Dana-Farber Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Johnson & Johnson Enterprise Innovation Inc.
University of Kentucky
Eastern Cooperative Oncology Group
Universität des Saarlandes
University of Utah
University of Florida
University of Virginia
Merck Sharp & Dohme LLC
Ohio State University Comprehensive Cancer Center
Zhejiang Cancer Hospital
University of California, Davis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
University of Michigan Rogel Cancer Center
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Brown University
West China Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
University of California, San Diego
Centre Antoine Lacassagne
Indiana University
Groupe Oncologie Radiotherapie Tete et Cou
University of Michigan Rogel Cancer Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Shandong Tumor Hospital
Fudan University
Oslo University Hospital
Thomas Jefferson University
Groupe Oncologie Radiotherapie Tete et Cou
Sun Yat-sen University
Case Comprehensive Cancer Center
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
The Clatterbridge Cancer Centre NHS Foundation Trust
University of Colorado, Denver
City of Hope Medical Center
Institut du Cancer de Montpellier - Val d'Aurelle
University of Pittsburgh
Beijing Tongren Hospital
Jules Bordet Institute
University of Chicago